CUTR (Cutera) Short Interest

View and export this data going back to 2004. Start your Free Trial

What is Cutera Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Cutera's Short Interest

For the Medical Devices subindustry, Cutera's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cutera's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cutera's Short Interest distribution charts can be found below:

* The bar in red indicates where Cutera's Short Interest falls into.

Cutera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cutera Inc (NAS:CUTR) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

TJ9:Germany

Address

3240 Bayshore Boulevard, Brisbane, CA, USA, 94005

Website

https://www.cutera.com

Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.

Executives

Michael Karavitis	officer: EVP, Chief Technology Officer	C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE CA 94005
Taylor C. Harris	director	6035 STONERIDGE DRIVE, PLEASANTON CA 94588
Stuart Drummond	officer: Interim Chief Financial Office	C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE CA 94005
Jeffrey S Jones	officer: Chief Operating Officer	C/O RELIANT TECHNOLOGIES, INC., 464 ELLIS STREET, MOUNTAIN VIEW CA 94043
Kevin J Cameron	director	C/O KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Keith J Sullivan	director	C/O RELIANT TECHNOLOGIES, INC., 464 ELLIS STREET, MOUNTAIN VIEW CA 94043
David H Mowry	director, officer: Chief Executive Officer	9775 TOLEDO, IRVINE CA 92618
Rohan Seth	officer: Chief Financial Officer	C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE CA 94005
Timothy J Oshea	director	C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE CA 94005
Juliane Park	director	C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE CA 94005
Janet D. Widmann	director	1411 E. MISSION AVENUE, SPOKANE WA 99202
J Daniel Plants	director	ONE EMBARCADERO CENTER, SUITE 1140, SAN FRANCISCO CA 94111
Katherine S Zanotti	director	431 E 9TH STREET, HINSDALE IL 60521
Joseph E Whitters	director